神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688520 神州细胞

已收盘 12-19 15:00:00

{"stockData":{"symbol":"688520","market":"SH","secType":"STK","nameCN":"神州细胞","latestPrice":37.72,"timestamp":1734591600000,"preClose":37.77,"halted":0,"volume":1142807,"delay":0,"floatShares":445000000,"shares":445000000,"eps":-0.0587,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.05,"latestTime":"12-19 15:00:00","open":37.51,"high":37.88,"low":37.2,"amount":42905400,"amplitude":0.018,"askPrice":37.75,"askSize":37,"bidPrice":37.72,"bidSize":12,"shortable":0,"etf":0,"ttmEps":-0.0587,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":37.77,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":41.55,"lowLimit":33.99,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":445335714,"pbRate":-39.2,"roa":"--","roe":"0.0%","epsLYR":-0.89,"committee":-0.342466,"marketValue":16798000000,"floatMarketCap":16798000000,"peRate":-642.589449,"changeRate":-0.0013,"turnoverRate":0.0026,"status":1,"afterMarket":{"amount":0,"volume":0,"close":37.72,"buyVolume":0,"sellVolume":0,"time":1734593638975,"indexStatus":"已收盘 12-19 15:30:00","preClose":37.77}},"requestUrl":"/m/hq/s/688520/tweets","defaultTab":"tweets","newsList":[{"id":"2492642809","title":"神州细胞-U12月17日遭主力抛售928万元 环比增加866.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492642809","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492642809?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:21","pubTimestamp":1734420078,"startTime":"0","endTime":"0","summary":"12月17日, 神州细胞-U股价跌2.08%，报收37.21元，成交金额5399万元，换手率0.32%，振幅2.76%，量比0.63。神州细胞-U今日主力资金净流出928万元，连续3日净流出，上一交易日主力净流出96万元，今日环比增加866.67%。该股近5个交易日下跌4.66%，主力资金累计净流出706万元；近20日主力资金累计净流出5198万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217154739ab7e818f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217154739ab7e818f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2491304559","title":"神州细胞更换2024年度审计机构，聘信永中和替代普华永道","url":"https://stock-news.laohu8.com/highlight/detail?id=2491304559","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491304559?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:11","pubTimestamp":1734081060,"startTime":"0","endTime":"0","summary":"财中社12月13日电神州细胞 发布关于变更公司2024年度审计机构的公告。公司拟聘任信永中和会计师事务所作为新的审计机构，替代原来的普华永道中天会计师事务所。信永中和会计师事务所成立于2012年，拥有245名合伙人和1656名注册会计师，2023年度业务收入为40.46亿元，其中审计业务收入为30.15亿元。2024年前三季度，神州细胞实现收入19.37亿元，归母净利润1.50亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213171409ab74e155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213171409ab74e155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486197318","title":"神州细胞-U11月27日遭主力抛售982万元 环比增加591.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486197318","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486197318?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:22","pubTimestamp":1732692169,"startTime":"0","endTime":"0","summary":"11月27日, 神州细胞-U股价涨1.67%，报收39.05元，成交金额6978万元，换手率0.41%，振幅3.38%，量比0.75。神州细胞-U今日主力资金净流出982万元，上一交易日主力净流出142万元，今日环比增加591.55%。|11月27日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|中仑新材|8.78%|#|恒信东方|7.99%|#|岭南股份|7.89%|#|康冠科技|6.15%|#|华如科技|6.12%|#|天地在线|5.89%|#|汇金科技|5.75%|#|汤姆猫|5.14%|#|方直科技|5.05%|#|跨境通|4.94%|神州细胞-U所在的生物制品行业，今日主力净流出1.50亿元，行业排名8/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127154234abe29f7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127154234abe29f7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2485336052","title":"11月22日神州细胞-U跌5.28%，招商核心优选股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485336052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485336052?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:21","pubTimestamp":1732263712,"startTime":"0","endTime":"0","summary":"证券之星消息，11月22日神州细胞-U跌5.28%，收盘报37.71元，换手率0.68%，成交量3.04万手，成交额1.17亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为招商核心优选股票A。张磊在任的基金产品包括:招商丰益混合A，管理时间为2020年1月18日至今，期间收益率为25.78%；招商核心优选股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200025883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2485287151","title":"神州细胞-U11月22日主力资金流出1011万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2485287151","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485287151?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:21","pubTimestamp":1732260096,"startTime":"0","endTime":"0","summary":"11月22日, 神州细胞-U股价跌5.28%，报收37.71元，成交金额1.17亿元，换手率0.68%，振幅5.73%，量比1.15。神州细胞-U今日主力资金净流出1011万元，连续3日净流出，上一交易日主力净流出566万元，今日环比增加78.62%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为66.67%，平均跌幅为2.37%。该股近5个交易日下跌4.05%，主力资金累计净流出1916万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4638万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122154625abd6c3e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122154625abd6c3e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2485681289","title":"神州细胞-U大跌 获5家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2485681289","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485681289?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:40","pubTimestamp":1732257618,"startTime":"0","endTime":"0","summary":"11月22日，神州细胞-U股价大幅下跌，截至14点40分，神州细胞-U下跌5.00%，报37.82元/股，成交1.01亿元，换手率0.59%。此外，数据统计显示，近半年内5家券商给予买入建议。资金动向截止发稿，神州细胞-U获得主力净流出845万元，其中超大单流出736万元，大单流出107万元。主营业务及业绩神州细胞-U公司主营业务为恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122144254a24d2cb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122144254a24d2cb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2485458792","title":"神州细胞-U11月21日遭主力抛售566万元 环比增加126.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485458792","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485458792?lang=zh_cn&edition=full","pubTime":"2024-11-21 15:20","pubTimestamp":1732173655,"startTime":"0","endTime":"0","summary":"11月21日, 神州细胞-U股价跌1.41%，报收39.81元，成交金额8282万元，换手率0.46%，振幅4.66%，量比0.69。神州细胞-U今日主力资金净流出566万元，上一交易日主力净流出250万元，今日环比增加126.40%。该股近5个交易日下跌3.51%，主力资金累计净流出2369万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出6323万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153620a24a9e4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153620a24a9e4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2484133385","title":"神州细胞-U大涨 新论坛召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2484133385","media":"智选洞察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484133385?lang=zh_cn&edition=full","pubTime":"2024-11-20 10:15","pubTimestamp":1732068914,"startTime":"0","endTime":"0","summary":"11月20日，神州细胞-U股价大幅上涨，截至10点15分，神州细胞-U上涨5.01%，报41.26元/股，突破40元整数关口，成交6269万元，换手率0.35%，振幅6.13%。资金动向截止发稿，神州细胞-U获得主力净流出111万元，其中超大单流出578万元，大单流入467万元。主营业务及业绩神州细胞-U公司主营业务为恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120101530a2473ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120101530a2473ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2483317286","title":"神州细胞-U11月15日遭主力抛售1463万元 环比增加137.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483317286","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483317286?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:20","pubTimestamp":1731655235,"startTime":"0","endTime":"0","summary":"11月15日, 神州细胞-U股价跌4.75%，报收39.30元，成交金额1.36亿元，换手率0.76%，振幅6.64%，量比0.61。神州细胞-U今日主力资金净流出1463万元，上一交易日主力净流出615万元，今日环比增加137.89%。该股近5个交易日下跌0.46%，主力资金累计净流出952万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1010万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115153519a23a269e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115153519a23a269e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2483469308","title":"神州细胞：安佳已与印尼、巴西等地伙伴签约，预计2025年开始在海外上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2483469308","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483469308?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:28","pubTimestamp":1731569336,"startTime":"0","endTime":"0","summary":"11月14日，神州细胞举办2024年第三季度业绩说明会。对于海外布局，管理层表示，公司产品安佳因已与印尼、巴西等国家的区域合作伙伴签约，利用合作方在当地的临床、注册和销售经验，正在努力推进在当地的商业化进程，预计将于2025年开始陆续在海外上市销售，目前尚无法确定具体销售规模。中国患者整体治疗水平离国际标准还相差较大。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153004a23685f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153004a23685f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2479636293","title":"神州细胞（688520）10月29日主力资金净卖出2933.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479636293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479636293?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:20","pubTimestamp":1730247621,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月29日收盘，神州细胞报收于38.01元，下跌6.82%，换手率1.28%，成交量5.72万手，成交额2.22亿元。近5日资金流向一览见下表：神州细胞融资融券信息显示，融资方面，当日融资买入1405.81万元，融资偿还967.03万元，融资净买入438.78万元。神州细胞主营业务：专注于恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2479226914","title":"神州细胞（688520）2024年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479226914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479226914?lang=zh_cn&edition=full","pubTime":"2024-10-30 06:18","pubTimestamp":1730240284,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期神州细胞发布2024年三季报。截至本报告期末，公司营业总收入19.37亿元，同比上升40.44%，归母净利润1.5亿元，同比上升168.17%。按单季度数据看，第三季度营业总收入6.32亿元，同比上升10.7%，第三季度归母净利润2424.83万元，同比上升129.53%。本报告期神州细胞盈利能力上升，毛利率同比增幅0.81%，净利率同比增幅49.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000005928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520"],"gpt_icon":0},{"id":"2479414244","title":"国金证券：给予神州细胞买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479414244","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479414244?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:55","pubTimestamp":1730174114,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司赵海春,袁维近期对神州细胞进行研究并发布了研究报告《八因子再创营利双增，RSV等多项研发蓄势中》，本报告对神州细胞给出买入评级，当前股价为38.77元。　　研发投入持续，管线丰富，创新RSV疫苗获批临床。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为62.84。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900018832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688520"],"gpt_icon":0},{"id":"2479411519","title":"神州细胞八因子再创营利双增，RSV等多项研发蓄势中","url":"https://stock-news.laohu8.com/highlight/detail?id=2479411519","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479411519?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:14","pubTimestamp":1730171685,"startTime":"0","endTime":"0","summary":"经营分析八因子再创营利双增，全年首次实现盈利在望。研发投入持续，管线丰富，创新RSV疫苗获批临床。公司目前4个产品获批，3个疫苗品种被国家纳入紧急使用，还有重组蛋白、双抗等诸多管线在研。除公司在自免领域有白介素等新产品在国内外展开临床外，2024年10月23日，公司又公告新增RSV疫苗获批临床。维持“买入”评级。风险提示新药研发及商业推广不达预期、对外合作不达预期等风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029113909a1f3de60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029113909a1f3de60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2479149753","title":"神州细胞-U大跌5.15% 获主力净流出1236万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479149753","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479149753?lang=zh_cn&edition=full","pubTime":"2024-10-29 09:50","pubTimestamp":1730166630,"startTime":"0","endTime":"0","summary":"10月29日，神州细胞-U股价大幅下跌，截至09点50分，神州细胞-U下跌5.15%，报38.69元/股，失守40元整数关口，成交6950万元，换手率0.39%。资金动向截止发稿，神州细胞-U获得主力净流出1236万元，其中超大单流出477万元，大单流出758万元。最新财报显示，今年三季报，神州细胞-U实现营业收入19.37亿元，同比增长40.44%，净利润为1.50亿元，同比增长168.17%，基本每股收益为0.34元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029095054ab7d0955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029095054ab7d0955&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2478428488","title":"神州细胞前三季度扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2478428488","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478428488?lang=zh_cn&edition=full","pubTime":"2024-10-28 20:21","pubTimestamp":1730118073,"startTime":"0","endTime":"0","summary":"新京报讯 10月28日，神州细胞发布2024年第三季度报告。今年前三季度，公司实现营业收入19.37亿元，同比增加40.44%；归属于上市公司股东的净利润1.5亿元；基本每股收益0.34元。其中，第三季度实现营业收入6.32亿元，同比增长10.7%；归属于上市公司股东的净利润2424.83万元。神州细胞称，营收增长主要因公司产品销售收入稳定增长所致。净利润较上年同期扭亏为盈，主要系公司产品销售收入稳定增长，以及通过控制运营成本、提高研发效率等方式降本增效所致。文章来源：新京报原标题：神州细胞前三季度扭亏为盈","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028210027ab7bb27b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028210027ab7bb27b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0},{"id":"2478993170","title":"神州细胞否认因涉嫌骗保被查，但其销售模式仍存争议","url":"https://stock-news.laohu8.com/highlight/detail?id=2478993170","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478993170?lang=zh_cn&edition=full","pubTime":"2024-10-28 18:16","pubTimestamp":1730110599,"startTime":"0","endTime":"0","summary":"据业内消息，因在核心产品安佳因销售过程中涉嫌骗保，神州细胞多位医药代表和地区经理已被警方带走调查。不到三年时间，神州细胞安佳因就创造了销售“神话”。据神州细胞2023年年报，2023年，神州细胞安佳因已占据同类产品市场占有率第一，实现销售额约17.8亿元。此外，神州细胞还曾通过另一项名为德义慈善“神州友爱-血友病患者援助”项目完成安佳因的销售现金返还。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028181811a1f1d2c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028181811a1f1d2c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520"],"gpt_icon":0},{"id":"2478178277","title":"神州细胞(688520.SH)发布前三季度业绩，净利润1.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478178277","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478178277?lang=zh_cn&edition=full","pubTime":"2024-10-28 16:19","pubTimestamp":1730103589,"startTime":"0","endTime":"0","summary":"智通财经APP讯，神州细胞(688520.SH)发布2024年第三季度报告，公司前三季度营业收入19.37亿元，同比增长40.44%;归属于上市公司股东的净利润1.5亿元;归属于上市公司股东的扣除非经常性损益的净利润4.62亿元，同比增长4778%;基本每股收益0.34元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688520"],"gpt_icon":0},{"id":"2478267137","title":"神州细胞-U10月25日遭主力抛售2696万元 环比增加742.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478267137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478267137?lang=zh_cn&edition=full","pubTime":"2024-10-25 15:19","pubTimestamp":1729840766,"startTime":"0","endTime":"0","summary":"10月25日, 神州细胞-U股价跌1.13%，报收40.34元，成交金额1.70亿元，换手率0.95%，振幅3.80%，量比1.11。神州细胞-U今日主力资金净流出2696万元，上一交易日主力净流出320万元，今日环比增加742.50%。该股近5个交易日上涨5.88%，主力资金累计净流入1712万元；近20日主力资金累计净流出1.35亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025153649a1e9507e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025153649a1e9507e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688520","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-22","address":"北京市通州区北京经济技术开发区科创七街31号院5号楼307","stockEarnings":[{"period":"1week","weight":-0.04},{"period":"1month","weight":-0.04},{"period":"3month","weight":0.174},{"period":"6month","weight":-0.1156},{"period":"1year","weight":-0.3142},{"period":"ytd","weight":-0.2998}],"companyName":"北京神州细胞生物技术集团股份公司","boardCode":"AI0027","perCapita":"43253股","boardName":"医药制造业","registeredCapital":"44533万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":"　　北京神州细胞生物技术集团股份公司是致力于研发具备差异化竞争优势生物药的创新型生物制药研发公司，专注于恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。公司的主要产品为重组蛋白药物、抗体药物等。公司在发现及研发创新药的领域拥有较强的能力，自主建立了从靶点蛋白筛选到候选药物的全套创新生物药发现上游技术平台体系。","serverTime":1734630736815,"listedPrice":25.64,"stockholders":"10296人(较上一季度增加3.33%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"神州细胞,688520,神州细胞股票,神州细胞股票老虎,神州细胞股票老虎国际,神州细胞行情,神州细胞股票行情,神州细胞股价,神州细胞股市,神州细胞股票价格,神州细胞股票交易,神州细胞股票购买,神州细胞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}